Researchers havee repurposed robotic technology normally used for synthetic biology research to help with testing for COVID-19.
Engineers have combined CRISPR with electronic transistors made from graphene to create a new hand-held device that can detect specific genetic mutations in a matter of minutes.
Researchers successfully used CRISPR/Cas9 to limit the impact of schistosomiasis and liver fluke infection, affecting more than a quarter of a billion people in Southeast Asia, sub-Saharan Africa, and Latin America.
Scientists plan to edit their genomes to correct rare genetic mutations and slow or halt progression of their diseases.
Research project is aimed at improving therapeutic options for both rare and common diseases, including supporting methods to improve editing the human genome.